Lyka Labs share news, announcements and annual reports
NSE: LYKALABSBSE: 500259Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹76.60.
2 Nov: open ₹76.00, high ₹76.00, low ₹75.07
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹271 Cr2,310th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.83
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −4.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 15,895
Lyka Labs share news and announcements
1,493 announcements, routine notices left out, newest first. Page 26 of 30.
Apr 2013
Mar 2013
7 Mar · Lyka Labs Ltd has informed BSE that Tarapur factory of the Company which was closed for modernization has completed modernization and plant has been upgraded. The Company has also obtained ....
Restarting of Commercial Production at Tarapur Factory
Feb 2013
14 Feb · Results
5 Feb · Board meeting
To consider and take on record Standalone Un-audited Financial Results and Consolidated Financial Results for the quarter ended December 31, 2012.
Nov 2012
15 Nov · Limited Review for Sep 30, 2012
12 Nov · Results
12 Nov · Board meeting
Company had informed the Exchange regarding a Board meeting to be held on November 10, 2012 To consider and take on record Standalone Un-audited Financial Results and Consolidated Financial Results for the quarter ended September 30, 2012.The Company has now informed the Exchange that the aforesaid Board meeting which was Convened on November 10, 2012 is now rescheduled on November 12, 2012.Not held on this date
3 Nov · Board meeting
To consider and take on record Standalone Un-audited Financial Results and Consolidated Financial Results for the quarter ended September 30, 2012.
Sep 2012
5 Sep · Lyka Labs Ltd has informed BSE that Mr. R. A. S. Iyer has resigned as a Director of the Company vide his letter dated August 14, 2012.
Resignation of Director5 Sep · Lyka Labs Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 28, 2012 to September 29, 2012 (both days inclusive) ....
Fixes Book Closure for AGM4 Sep · Management
Mr. R.A.S. Iyer has resigned as a Director of the Company vide its letter dated August 14,2012.4 Sep · Meeting
Annual General Meeting is convened on September 29, 2012. Further the book Closure period for the purpose of AGM is fixed from September 28, 2012 to September 29, 2012 (both days inclusive).
Aug 2012
24 Aug · Board meeting
For adoption of Annual Accounts for the year ended March 31, 2012.17 Aug · Limited Review for June 30, 2012
14 Aug · Results
3 Aug · Board meeting
To consider and take on record the Unaudited Financial Results and Consolidated Financial Results for the quarter ended June 30, 2012.
Jul 2012
3 Jul · Meeting
Company are required to hold AGM for the Financial Year of 18 months period ended March 31, 2012 by July 29, 2012. The Company have sought permission from the Register of Companies, Gujarat vide their letter dated June 28, 2012 to hold AGM upto September 30, 2012.
May 2012
18 May · Limited Review for March 31, 2012
15 May · Results
4 May · Board meeting
To consider and take on record the Un-audited Financial Results and also Consolidated Financial Results of the Company for the quarter ended March 31, 2012.
Apr 2012
3 Apr · Lyka Labs Ltd has informed BSE that at the Board Meeting held on March 29, 2012, the Board of Directors have appointed Mr. V. Shanbhag as Director of the Company.
Appointment of Director3 Apr · Management
At the Board Meeting held on March 29, 2012, the Board of Directors have appointed Mr. V.Shanbhag as Director of the Company.
Mar 2012
30 Mar · Board meeting
At the Board Meeting held on March 29, 2012 the Board has deferred transfer / sale of the Company's R&D Division to its wholly owned subsidiary Company.30 Mar · Lyka Labs Ltd has informed BSE that the Board of the Directors of the Company at its meeting held on March 29, 2012, the Board has deferred transfer / sale of Company's R&D Division to ....
Outcome of Board Meeting26 Mar · Board meeting
To consider transfer / sale of the Company's R&D Centre to its wholly owned subsidiary Company.26 Mar · Lyka Labs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 29, 2012 to consider transfer / sale of the Company's R&D Centre to its wholly ....
Board Meeting on March 29, 2012
Feb 2012
14 Feb · Results
4 Feb · Board meeting
To consider and take on record the Un-audited Financial Results and also Consolidated Financial Results of the Company for the quarter ended December 31, 2011.
Jan 2012